Araris Biotech

News

Taiho has reached a deal to buy Swiss biotech Araris, around 18 months after they started collaborating on antibody-drug conjugates for cancer.

News

TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.